The TargetEd MAnageMent Intervention for Reducing Stroke Risk in Black Men: A 6-Month Prospective Randomized Controlled Trial.

This 6-month randomized controlled trial compared TEAM, a group intervention to reduce stroke risk versus a 6-month wait-list control in Black men with stroke or transient ischemic attack. The primary outcome was the change from baseline to 6 months in systolic blood pressure (SBP). There were 160 randomized, N = 78 to TEAM, N = 82 to Waitlist, mean age 61.2 (SD 9.5). Attrition was 53.1% and similar across arms. Biomarker values were extracted from health records for individuals with missed visits. Baseline SBP was 135.3 (SD 17.9). Among the entire sample, SBP was numerically but not statistically significantly reduced with no significant difference between TEAM versus Waitlist. Post-hoc analyses suggested those with elevated baseline blood pressure (BP) had significant BP reduction in the group as a whole and in TEAM. Future research might target Black men with poorly controlled BP and address barriers to engaging in risk reduction programs.